If he had not received treatment, he likely would have never grown to a normal height
Korean Society of Cardiovascular Pharmacotherapy
Collectively, the results discussed above could be interpreted to suggest that conditions likely to result in -cell stress, such as obesity, hyperglycaemia, and inflammation, activate compensatory responses in an attempt to improve -cell function and survival
Many individuals with Hashimoto's thyroiditis also have type 2 diabetes or obesityconditions for which GLP-1 medications are indicatedand can safely receive these treatments under appropriate medical supervision
Cardiovascular Benefits: Semaglutide has shown potential in reducing cardiovascular risk factors, making it an attractive option for individuals with obesity-related heart health concerns
Their manufacturing, packaging, delivery, and disposal leave a heavy footprint that healthcare systems cannot afford to ignore if they are serious about net-zero commitments [17][18]